A detailed history of Covestor LTD transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Covestor LTD holds 6 shares of KURA stock, worth $120. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6
Previous 10 40.0%
Holding current value
$120
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$13.42 - $23.53 $53 - $94
-4 Reduced 40.0%
6 $0
Q4 2023

Feb 09, 2024

SELL
$7.58 - $14.38 $7 - $14
-1 Reduced 9.09%
10 $0
Q3 2023

Nov 13, 2023

BUY
$8.44 - $11.86 $33 - $47
4 Added 57.14%
11 $0
Q4 2022

Feb 13, 2023

SELL
$11.23 - $16.9 $11 - $16
-1 Reduced 12.5%
7 $0
Q3 2022

Nov 14, 2022

BUY
$12.01 - $19.45 $96 - $155
8 New
8 $0

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $1.34B
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.